These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 6831654

  • 1. Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries.
    Godfraind T, Miller RC.
    Circ Res; 1983 Feb; 52(2 Pt 2):I81-91. PubMed ID: 6831654
    [Abstract] [Full Text] [Related]

  • 2. Actions of nifedipine on calcium fluxes and contraction in isolated rat arteries.
    Godfraind T.
    J Pharmacol Exp Ther; 1983 Feb; 224(2):443-50. PubMed ID: 6822965
    [Abstract] [Full Text] [Related]

  • 3. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.
    Hondeghem LM, Ayad MJ, Robertson RM.
    J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin.
    Godfraind T, Dessy C, Salomone S.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):112-22. PubMed ID: 1403776
    [Abstract] [Full Text] [Related]

  • 5. The mechanisms of the direct action of etomidate on vascular reactivity in rat mesenteric resistance arteries.
    Shirozu K, Akata T, Yoshino J, Setoguchi H, Morikawa K, Hoka S.
    Anesth Analg; 2009 Feb; 108(2):496-507. PubMed ID: 19151278
    [Abstract] [Full Text] [Related]

  • 6. Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle.
    Morel N, Godfraind T.
    J Pharmacol Exp Ther; 1987 Nov; 243(2):711-5. PubMed ID: 2824756
    [Abstract] [Full Text] [Related]

  • 7. Induction of Ca++ influx and intracellular Ca++ release in isolated rat aorta and mesenteric resistance vessels by norepinephrine activation of alpha-1 receptors.
    Cauvin C, Malik S.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):413-8. PubMed ID: 6086886
    [Abstract] [Full Text] [Related]

  • 8. Intervessel (arteries and veins) and heart/vessel selectivities of therapeutically used calcium entry blockers: variable, vessel-dependent indexes.
    Magnon M, Gallix P, Cavero I.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1157-66. PubMed ID: 8531077
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacological studies on alterations in contractile reactivity in aortas isolated from experimental diabetic rats].
    Kawasaki H.
    Hokkaido Igaku Zasshi; 1997 Nov; 72(6):649-65. PubMed ID: 9465317
    [Abstract] [Full Text] [Related]

  • 10. The inhibition by flunarizine of the norepinephrine-evoked contraction and calcium influx in rat aorta and mesenteric arteries.
    Godfraind T, Dieu D.
    J Pharmacol Exp Ther; 1981 May; 217(2):510-5. PubMed ID: 7229987
    [No Abstract] [Full Text] [Related]

  • 11. Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries.
    Ghisdal P, Vandenberg G, Morel N.
    J Physiol; 2003 Sep 15; 551(Pt 3):855-67. PubMed ID: 12853654
    [Abstract] [Full Text] [Related]

  • 12. Calcium entry blockers and receptor-response coupling.
    Godfraind T.
    J Cardiovasc Pharmacol; 1982 Sep 15; 4 Suppl 3():S269-72. PubMed ID: 6184551
    [Abstract] [Full Text] [Related]

  • 13. Effects of Ca antagonists on Ca fluxes in resistance vessels.
    Cauvin C, Saida K, van Breemen C.
    J Cardiovasc Pharmacol; 1982 Sep 15; 4 Suppl 3():S287-90. PubMed ID: 6184554
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
    Zakhari S.
    Drugs Exp Clin Res; 1986 Sep 15; 12(9-10):817-29. PubMed ID: 3539569
    [Abstract] [Full Text] [Related]

  • 15. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
    Priviero FB, Teixeira CE, Toque HA, Claudino MA, Webb RC, De Nucci G, Zanesco A, Antunes E.
    Clin Exp Pharmacol Physiol; 2006 Sep 15; 33(5-6):448-55. PubMed ID: 16700877
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei C, Leonardi A, Testa R.
    Arzneimittelforschung; 1996 Jan 15; 46(1):15-24. PubMed ID: 8821512
    [Abstract] [Full Text] [Related]

  • 18. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery.
    Noguera I, Medina P, Segarra G, Martínez MC, Aldasoro M, Vila JM, Lluch S.
    Br J Pharmacol; 1997 Oct 15; 122(3):431-8. PubMed ID: 9351498
    [Abstract] [Full Text] [Related]

  • 19. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM, Vanhoutte PM.
    Fed Proc; 1981 Dec 15; 40(14):2862-5. PubMed ID: 7308496
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological actions of benidipine hydrochloride in several isolated smooth muscles and myocardium.
    Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N.
    Arzneimittelforschung; 1988 Nov 15; 38(11A):1722-30. PubMed ID: 3219148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.